Stanley Laman Group, Ltd. Exact Sciences Corp Transaction History
Stanley Laman Group, Ltd.
- $648 Million
- Q3 2024
A detailed history of Stanley Laman Group, Ltd. transactions in Exact Sciences Corp stock. As of the latest transaction made, Stanley Laman Group, Ltd. holds 93,550 shares of EXAS stock, worth $6.51 Million. This represents 0.98% of its overall portfolio holdings.
Number of Shares
93,550
Previous 108,418
13.71%
Holding current value
$6.51 Million
Previous $4.58 Million
39.06%
% of portfolio
0.98%
Previous 0.72%
Shares
6 transactions
Others Institutions Holding EXAS
# of Institutions
637Shares Held
166MCall Options Held
1.93MPut Options Held
1.23M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.27 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.5MShares$1.15 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA14.8MShares$1.03 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$840 Million0.01% of portfolio
-
State Street Corp Boston, MA8.21MShares$572 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $12.3B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...